SMMNY:OTC-Siemens Healthineers AG ADR (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 29.055

Change

+0.35 (+1.20)%

Market Cap

USD 63.37B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

N/A

USD 63.76B
RYLPF Koninklijke Philips N.V

N/A

USD 29.83B
SONVF Sonova Holding AG

N/A

USD 22.04B
SNWV SANUWAVE Health Inc

-1.50 (-7.89%)

USD 20.67B
SNNUF Smith & Nephew plc

+0.01 (+0.03%)

USD 12.78B
WILLF Demant A/S

N/A

USD 8.72B
GNGBF Getinge AB

N/A

USD 5.12B
AMBFF Ambu A/S

N/A

USD 4.94B
AMBBY Ambu A/S

N/A

USD 4.94B
GGNDF GN Store Nord A/S

N/A

USD 3.10B

ETFs Containing SMMNY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.26% 58% F 49% F
Dividend Return 1.77% 63% D 44% F
Total Return 1.52% 62% D 50% F
Trailing 12 Months  
Capital Gain 2.13% 72% C 62% D
Dividend Return 1.82% 73% C 23% F
Total Return 3.94% 72% C 61% D-
Trailing 5 Years  
Capital Gain 41.84% 79% B- 78% C+
Dividend Return 2.52% 36% F 7% C-
Total Return 44.36% 79% B- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 9.55% 55% F 55% F
Dividend Return 9.57% 54% F 51% F
Total Return 0.03% 5% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 23.67% 90% A- 81% B-
Risk Adjusted Return 40.44% 89% A- 78% C+
Market Capitalization 63.37B 99% N/A 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.